New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
Milan, Italy: New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for...